logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Use of protease inhibitors among persons with AIDS in Los Angeles County.

    Article - En anglais

    We evaluated the access to, and the factors associated with, protease inhibitor use among persons with AIDS in Los Angeles County.

    A population-based sample of adult persons with AIDS is routinely interviewed in Los Angeles County and includes a 30% random sample of men who have sex with men and all other persons reported with AIDS.

    Since May of 1996, all participants were asked if their physician had ever prescribed a protease inhibitor for their use.

    The possible association between protease inhibitor use and sociodemographic, temporal and health care factors was assessed for the 12-month period May 1996 through April 1997.

    Logistic regression was employed for multivariate analysis.

    Over the 12-month study period, 61.7% (209/339) persons interviewed reported that their physician had prescribed a protease inhibitor as part of their therapy.

    In bivariate analysis, treatment with protease inhibitor use was more common for whites (71.4%) and US-born Latinos (68.2%) than blacks (53.4%) and foreign-born Latinos (56.6%), among person of higher income (71.2%) than lower (<$10,000) income (50.3%), in those who reported having insurance (66. 7%) than those uninsured (47%) and among persons receiving care at private clinics (86.4%) than at HMOs (63.4%) or public clinics (55.2%). An increasing trend of protease inhibitor use with higher educational level and declining CD4+count was observed. (...)

    Mots-clés Pascal : SIDA, Virose, Infection, Prescription médicale, Inhibiteur protease, Service santé, Etats Unis, Amérique du Nord, Amérique, Accessibilité, Homme, Immunopathologie, Immunodéficit

    Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Medical prescription, Protease inhibitor, Health service, United States, North America, America, Accessibility, Human, Immunopathology, Immune deficiency

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0255363

    Code Inist : 002B30A03A. Création : 16/11/1999.